- Home
- DIBS vs ABOS Comparison
DIBS vs ABOS Comparison
Compare DIBS & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- ABOS
- Stock Information
- Founded
- DIBS 2000
- ABOS 1996
- Country
- DIBS United States
- ABOS United States
- Employees
- DIBS N/A
- ABOS N/A
- Industry
- DIBS Catalog/Specialty Distribution
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- ABOS Health Care
- Exchange
- DIBS Nasdaq
- ABOS Nasdaq
- Market Cap
- DIBS 99.7M
- ABOS 113.9M
- IPO Year
- DIBS 2021
- ABOS 2021
- Fundamental
- Price
- DIBS $3.89
- ABOS $2.23
- Analyst Decision
- DIBS Hold
- ABOS Strong Buy
- Analyst Count
- DIBS 1
- ABOS 3
- Target Price
- DIBS N/A
- ABOS $8.00
- AVG Volume (30 Days)
- DIBS 75.7K
- ABOS 458.5K
- Earning Date
- DIBS 11-07-2025
- ABOS 11-11-2025
- Dividend Yield
- DIBS N/A
- ABOS N/A
- EPS Growth
- DIBS N/A
- ABOS N/A
- EPS
- DIBS N/A
- ABOS N/A
- Revenue
- DIBS $88,640,000.00
- ABOS N/A
- Revenue This Year
- DIBS $2.87
- ABOS N/A
- Revenue Next Year
- DIBS $3.26
- ABOS N/A
- P/E Ratio
- DIBS N/A
- ABOS N/A
- Revenue Growth
- DIBS 3.21
- ABOS N/A
- 52 Week Low
- DIBS $2.30
- ABOS $0.86
- 52 Week High
- DIBS $4.39
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- DIBS 89.07
- ABOS 63.20
- Support Level
- DIBS $2.55
- ABOS $1.85
- Resistance Level
- DIBS $4.10
- ABOS $2.46
- Average True Range (ATR)
- DIBS 0.18
- ABOS 0.20
- MACD
- DIBS 0.13
- ABOS -0.00
- Stochastic Oscillator
- DIBS 87.74
- ABOS 71.97
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.